Position in ONC
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$284
-$12 QoQ
Shares Held
1
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#281
of 282 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Abound Wealth Management holds $379,467 across 22 Biotechnology names. ONC ranks #12 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TGTX |
Tg Therapeutics, Inc.
|
3,506 | $192,619 | |
| 2 | TECH |
BIO-TECHNE Corp
|
1,192 | $84,214 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
51 | $31,800 | |
| 4 | ARGX |
Argenx SE
|
32 | $29,688 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
50 | $24,836 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
225 | $12,271 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4 | $1,204 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
2 | $374 |
All Filings in ONC
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $284 | 1 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $296 | 1 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $303 | 1 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $340 | 1 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $242 | 1 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $272 | 1 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $184 | 1 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $224 | 1 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $142 | 1 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $156 | 1 | Shares | Sole | 2024-08-08 | |
| 2023-12-31 | $180 | 1 | Shares | Sole | 2024-08-08 | |
| 2023-09-30 | $179 | 1 | Shares | Sole | 2024-08-08 | |
| 2023-06-30 | $178 | 1 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||